Title Credit Type Event date Cost
Predicting Risk: Current Research and New Therapies for Optimal Management of Colorectal Cancer
    • 1.00 ACPE - Pharmacist
    • 1.00 ACPE - Pharmacy Technician
    • 1.00 AMA
    • 1.00 ANCC
    • 1.00 Attendance
    • 1.00 CCMC - General
Enduring $0.00
Advances in CAR T-Cell Immunotherapy in Leukemia
    • 0.75 ACPE - Pharmacist
    • 0.75 ACPE - Pharmacy Technician
    • 0.75 AMA
    • 0.75 ANCC
    • 0.75 Attendance
    • 0.75 CCMC - General
Enduring $0.00
New Insights into Chimeric Antigen Receptor (CAR) T-Cell Therapy
    • 1.00 ACPE - Pharmacist
    • 1.00 ACPE - Pharmacy Technician
    • 1.00 AMA
    • 1.00 ANCC
    • 1.00 Attendance
    • 1.00 CCMC - General
Enduring $0.00
Precision Medicine in Cancer Care
    • 1.00 ACPE - Pharmacist
    • 1.00 ACPE - Pharmacy Technician
    • 1.00 AMA
    • 1.00 ANCC
    • 1.00 Attendance
    • 1.00 CCMC - General
Enduring $0.00
Therapeutic Strategies in the Treatment of Hodgkin Lymphoma
    • 1.25 ACPE - Pharmacist
    • 1.25 ACPE - Pharmacy Technician
    • 1.25 ANCC
    • 1.25 Attendance
    • 1.25 CCMC - General
Enduring $0.00
Treatment Strategies for Acute Lymphoblastic Leukemia: From Adolescents to Adults
    • 1.00 ACPE - Pharmacist
    • 1.00 ACPE - Pharmacy Technician
    • 1.00 AMA
    • 1.00 ANCC
    • 1.00 Attendance
    • 1.00 CCMC - General
Enduring $0.00
Big Data: Integrated Cancer Information for Population-Based Research
    • 1.00 ACPE - Pharmacist
    • 1.00 ACPE - Pharmacy Technician
    • 1.00 AMA
    • 1.00 ANCC
    • 1.00 Attendance
    • 1.00 CCMC - General
Enduring $0.00
Successes and Challenges with Chimeric Antigen Receptor T-Cell Therapy
    • 1.00 ACPE - Pharmacist
    • 1.00 ACPE - Pharmacy Technician
    • 1.00 AMA
    • 1.00 ANCC
    • 1.00 Attendance
    • 1.00 CCMC - General
Enduring $0.00
Prostate Cancer: Guideline Recommendations and Emerging Therapies
    • 1.00 ACPE - Pharmacist
    • 1.00 ACPE - Pharmacy Technician
    • 1.00 AMA
    • 1.00 ANCC
    • 1.00 Attendance
    • 1.00 CCMC - General
Enduring $0.00
Chimeric Antigen Receptor T-Cell Therapy: A Cure for Cancer?
    • 1.00 ACPE - Pharmacist
    • 1.00 ACPE - Pharmacy Technician
    • 1.00 AMA
    • 1.00 ANCC
    • 1.00 Attendance
    • 1.00 CCMC - General
Enduring $0.00
Best Practices and Emerging Therapies for Myelodysplastic Syndromes (MDS)
    • 1.00 ACPE - Pharmacist
    • 1.00 ACPE - Pharmacy Technician
    • 1.00 AMA
    • 1.00 ANCC
    • 1.00 Attendance
    • 1.00 CCMC - General
Enduring $0.00
Chimeric Antigen Receptor (CAR) T-cell Therapy
    • 1.00 ACPE - Pharmacist
    • 1.00 ACPE - Pharmacy Technician
    • 1.00 AMA
    • 1.00 ANCC
    • 1.00 Attendance
    • 1.00 CCMC - General
Enduring $0.00
Colorectal Cancer: Screening Guidelines and Genetic Biomarker Testing
    • 1.00 ACPE - Pharmacist
    • 1.00 ACPE - Pharmacy Technician
    • 1.00 AMA
    • 1.00 ANCC
    • 1.00 Attendance
    • 1.00 CCMC - General
Enduring $0.00
Multiple Myeloma: What’s New in Treatment Options
    • 1.00 ACPE - Pharmacist
    • 1.00 ACPE - Pharmacy Technician
    • 1.00 AMA
    • 1.00 ANCC
    • 1.00 Attendance
    • 1.00 CCMC - General
Enduring $0.00
Hepatocellular Carcinoma: Treatment Options Outside of Transplant
    • 1.00 ACPE - Pharmacist
    • 1.00 ACPE - Pharmacy Technician
    • 1.00 AMA
    • 1.00 ANCC
    • 1.00 Attendance
    • 1.00 CCMC - General
Enduring $0.00

Pages